← Leaderboards
Robert A Davey
Washington University
$11,727,915
Attributed
$15,133,485
Total exposure
15
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $12.6M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$26,633,485 · 16
By mechanism
UC7$11,500,000 · 1
R01$7,642,626 · 3
P01$4,547,008 · 3
R21$1,743,484 · 3
R41$438,476 · 1
U54$355,339 · 2
Top collaborators
- Douglas J. Lacount6 shared
- Vincent Jo Davisson4 shared
- Sean Ekins2 shared
Most similar at Washington University
Same institution · by research overlap
- Christopher F Basler$44,557,002
- Gaya K. Amarasinghe$21,435,025
- Abraham Jaleel Qavi$758,851
- Grace Uwase$69,810
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionVirusCellsVirus DiseasesProteinsEbola VirusPathway InteractionsPharmaceutical PreparationsFilovirusPathogenProgramsViralInsightDesignSmall MoleculeAntiviral AgentsVirus ReplicationBiochemicalMouse ModelDependenceIntegration Host FactorsComplexCategoriesSmall Interfering Rna
Grant awards (44)
National Emerging Infectious Diseases Laboratories Operations$11,500,000
UC7 · FY2025 · AI · contact PI
Roles of host factor protein subnetworks in regulating steps of filovirus infection$707,964
P01 · FY2025 · AI · contact PI
High Biocontainment (BSL4/ABSL4) core for replication competent virus work$436,212
P01 · FY2025 · AI · contact PI
Roles of host factor protein subnetworks in regulating steps of filovirus infection$603,735
P01 · FY2024 · AI · contact PI
High Biocontainment (BSL4/ABSL4) core for replication competent virus work$357,893
P01 · FY2024 · AI · contact PI
Roles of host factor protein subnetworks in regulating steps of filovirus infection$627,613
P01 · FY2023 · AI · contact PI
High Biocontainment (BSL4/ABSL4) core for replication competent virus work$371,762
P01 · FY2023 · AI · contact PI
Antiviral Lead Identification to Treat Filovirus Infections$637,035
R01 · FY2022 · AI
Antiviral Lead Identification to Treat Filovirus Infections$621,031
R01 · FY2021 · AI
Antiviral Lead Identification to Treat Filovirus Infections$704,383
R01 · FY2020 · AI
Virology BSL4 Core$160,000
P01 · FY2020 · AI · contact PI
Emerging virus-host cell protein interaction networks$711,675
R01 · FY2019 · AI
Antiviral Lead Identification to Treat Filovirus Infections$639,566
R01 · FY2019 · AI
Virology BSL4 Core$260,000
P01 · FY2019 · AI · contact PI
Emerging virus-host cell protein interaction networks$734,925
R01 · FY2018 · AI
Virology BSL4 Core$296,825
P01 · FY2018 · AI · contact PI
Emerging virus-host cell protein interaction networks$734,925
R01 · FY2017 · AI
Virology BSL4 Core$327,250
P01 · FY2017 · AI · contact PI
Repurposing pyronaridine as a treatment for the Ebola virus$312,390
R21 · FY2017 · TR
Emerging virus-host cell protein interaction networks$734,925
R01 · FY2016 · AI
Virology BSL4 Core$397,754
P01 · FY2016 · AI · contact PI
Repurposing pyronaridine as a treatment for the Ebola virus$288,801
R21 · FY2016 · TR
Novel broad spectrum inhibitors of filovirus infection$231,250
R21 · FY2016 · AI · contact PI
Development of a Broad Spectrum Antiviral for Ebola and Marburg viral Infections$110,265
R41 · FY2016 · AI · contact PI
Emerging virus-host cell protein interaction networks$624,607
R01 · FY2015 · AI
Development of a Broad Spectrum Antiviral for Ebola and Marburg viral Infections$328,211
R41 · FY2015 · AI · contact PI
Novel broad spectrum inhibitors of filovirus infection$277,500
R21 · FY2015 · AI · contact PI
Emerging virus-host cell protein interaction networks$66,878
R56 · FY2015 · AI
Receptor Trafficking in Entry of Murine Leukemia Viruses$188,406
R01 · FY2011 · AI · contact PI
Receptor Trafficking in Entry of Murine Leukemia Viruses$87,857
R01 · FY2011 · AI · contact PI
Receptor Trafficking in Entry of Murine Leukemia Viruses$249,194
R01 · FY2010 · AI · contact PI
HTS for Filo- and Arena-virus Entry Mechanisms$37,174
R03 · FY2010 · MH · contact PI
Receptor Trafficking in Entry of Murine Leukemia Viruses$251,711
R01 · FY2009 · AI · contact PI
Nanoparticle Analysis of Enveloped Virus Entry Pathways$159,977
R21 · FY2009 · GM · contact PI
Discovery & Characterization of Filo-. Arena -and Alpha Virus Entry Inhibitors$152,129
U54 · FY2009 · AI · contact PI
Nanoparticle Analysis of Enveloped Virus Entry Pathways$123,533
R21 · FY2009 · GM · contact PI
Nanoparticle Analysis of Enveloped Virus Entry Pathways$123,533
R21 · FY2009 · GM · contact PI
HTS for Filo- and Arena-virus Entry Mechanisms$38,250
R03 · FY2009 · MH · contact PI
Receptor Trafficking in Entry of Murine Leukemia Viruses$251,711
R01 · FY2008 · AI · contact PI
Nanoparticle Analysis of Enveloped Virus Entry Pathways$226,500
R21 · FY2008 · GM · contact PI
Discovery and characterization of new therapeutics against filoviruses$203,210
U54 · FY2008 · AI · contact PI
Receptor Trafficking in Entry of Murine Leukemia Viruses$256,587
R01 · FY2007 · AI · contact PI
Receptor Trafficking in Entry of Murine Leukemia Viruses$214,088
R01 · FY2006 · AI · contact PI
Receptor Trafficking in Entry of Murine Leukemia Viruses$264,250
R56 · FY2005 · AI